Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
10,570
Total Claims
$1.1M
Drug Cost
750
Beneficiaries
$1,432
Cost/Patient
Risk Score Breakdown 12/100
Score components are additive. Read full methodology
Peer Comparison vs. 109,535 Physician Assistant providers
-57%
Opioid rate vs peers
4.0% vs 9.2% avg
+99%
Cost per patient vs peers
$1,432 vs $719 avg
+131%
Brand preference vs peers
15.4% vs 6.7% avg
Opioid Prescribing
4.0%
Opioid Rate
422
Opioid Claims
$10K
Opioid Cost
4.0%
Long-Acting Rate
Brand vs Generic
Brand: 1,604 claims · $905K
Generic: 8,836 claims · $159K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Dulaglutide | 75 | $97K |
| Sitagliptin Phosphate | 63 | $74K |
| Semaglutide | 47 | $65K |
| Apixaban | 61 | $60K |
| Empagliflozin | 40 | $52K |
| Budesonide/Formoterol Fumarate | 95 | $51K |
| Insulin Glargine,hum.Rec.Anlog | 85 | $41K |
| Linagliptin | 42 | $40K |
| Tiotropium Bromide | 32 | $27K |
| Rivaroxaban | 28 | $24K |
| Fluticasone Propion/Salmeterol | 29 | $22K |
| Insulin Detemir | 31 | $21K |
| Fluticasone/Umeclidin/Vilanter | 28 | $20K |
| Insulin Lispro | 24 | $16K |
| Insulin Regular, Human | 24 | $15K |
Prescribing Profile
Patient Profile
68
Avg Age
59%
Female
2.04
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data